What can neuroimaging of neuromodulation reveal about the basis of circuit therapies for psychiatry?
- PMID: 39198580
- PMCID: PMC11526173
- DOI: 10.1038/s41386-024-01976-2
What can neuroimaging of neuromodulation reveal about the basis of circuit therapies for psychiatry?
Erratum in
-
Correction: Neuropsychopharmacology Volume 50 Issue 1.Neuropsychopharmacology. 2025 May;50(6):1019-1020. doi: 10.1038/s41386-025-02087-2. Neuropsychopharmacology. 2025. PMID: 40108440 Free PMC article. No abstract available.
Abstract
Neuromodulation is increasingly becoming a therapeutic option for treatment resistant psychiatric disorders. These non-invasive and invasive therapies are still being refined but are clinically effective and, in some cases, provide sustained symptom reduction. Neuromodulation relies on changing activity within a specific brain region or circuit, but the precise mechanisms of action of these therapies, is unclear. Here we review work in both humans and animals that has provided insight into how therapies such as deep brain and transcranial magnetic stimulation alter neural activity across the brain. We focus on studies that have combined neuromodulation with neuroimaging such as PET and MRI as these measures provide detailed information about the distributed networks that are modulated and thus insight into both the mechanisms of action of neuromodulation but also potentially the basis of psychiatric disorders. Further we highlight work in nonhuman primates that has revealed how neuromodulation changes neural activity at different scales from single neuron activity to functional connectivity, providing key insight into how neuromodulation influences the brain. Ultimately, these studies highlight the value of combining neuromodulation with neuroimaging to reveal the mechanisms through which these treatments influence the brain, knowledge vital for refining targeted neuromodulation therapies for psychiatric disorders.
© 2024. The Author(s), under exclusive licence to American College of Neuropsychopharmacology.
Conflict of interest statement
HM and KSC receive consulting fees from Abbott Neuromodulation. Other authors declare no competing financial interest.
References
-
- Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, et al. Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45:651–60. - PubMed
-
- Herrera-Melendez A-L, Bajbouj M, Aust S. Application of transcranial direct current stimulation in psychiatry. Neuropsychobiology. 2020;79:372–83. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- UH3 NS103550/NS/NINDS NIH HHS/United States
- 28979/Brain and Behavior Research Foundation (Brain & Behavior Research Foundation)
- UH3NS103550/U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
- R01MH132789/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- NA/Hope for Depression Research Foundation (Depression Research Foundation)
LinkOut - more resources
Full Text Sources
Medical